AI powered platform that unifies genomic, proteomics and transcriptomic foundation models to identify clinically actionable drug targets and biomarkers. OmicxIQ.Ai provides a comprehensive understanding of variant pathogenicity and disease relevance. Helps researchers and drug development companies design therapeutice solutions.